SuperworthSTERIS profit margin STE
Gross, operating and net profit as a share of revenue over the last twelve months, from 2019.
- Net margin, 12 months
- 13.3%
- Operating margin, 12 months
- 18.9%
- Net margin on a year earlier
- +1.7 pts
- Peer median
- 13.6%
Over the twelve months to Jun 30, 2026, STERIS kept 13.3% of its revenue as net profit, with an operating margin of 18.9% and a gross margin of 44.4%.
Five years earlier its net margin was 8.4%.
The median for 10 healthcare stocks of a similar size is 13.6%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2026 | 13.2% | 18.6% | 44.2% |
| FY2025 | 11.3% | 15.9% | 44.0% |
| FY2024 | 7.4% | 16.3% | 43.2% |
| FY2023 | 2.4% | 5.9% | 43.7% |
| FY2022 | 5.3% | 9.3% | 44.0% |
| FY2021 | 12.8% | 17.6% | 43.2% |
| FY2020 | 13.5% | 17.7% | 43.6% |
| FY2019 | 10.9% | 14.8% | 42.2% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q1 FY27 | 13.3% | +1.7 pts | 18.9% | |
| Q4 FY26 | 13.2% | +1.9 pts | 18.6% | |
| Q3 FY26 | 12.1% | +3.5 pts | 17.2% | |
| Q2 FY26 | 12.1% | +3.9 pts | 17.1% | |
| Q1 FY26 | 11.6% | +4.0 pts | 16.6% | |
| Q4 FY25 | 11.3% | +3.9 pts | 15.9% | |
| Q3 FY25 | 8.7% | −2.7 pts | 16.1% | |
| Q2 FY25 | 8.2% | −3.3 pts | 16.0% | |
| Q1 FY25 | 7.6% | +5.1 pts | 15.7% | |
| Q4 FY24 | 7.4% | +5.0 pts | 16.3% | |
| Q3 FY24 | 11.3% | +12.0 pts | 16.8% | |
| Q2 FY24 | 11.4% | +11.6 pts | 16.7% |
Against its peers
Companies in Healthcare nearest STERIS' size, closest first, today.
| Company | Profit margin |
|---|---|
| STESTERIS | 13.3% |
| INCYIncyte | 27.7% |
| THCTenet Healthcare | 10.3% |
| UTHRUnited Therapeutics | 41.6% |
| LHLabcorp | 7.0% |
| DGXQuest Diagnostics | 9.2% |
| ZBHZimmer Biomet | 9.5% |
| MEDPMedpace | 17.7% |
| WSTWest Pharmaceutical Services | 17.0% |
| RVTYRevvity | 8.2% |
| DXCMDexCom | 20.1% |
| Peer median | 13.6% |
Where STERIS ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on STERIS
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.